Methylprednisolone inhibits the expression of glial fibrillary acidic protein and chondroitin sulfate proteoglycans in reactivated astrocytes
暂无分享,去创建一个
Yi-Hsuan Lee | Liang‐Yo Yang | S. Tsai | Shin-Han Tsai | W. V. Yang | Yu-Yo Sun | Wei‐Lin Liu | C. Hsu | W. Yang
[1] S. McMahon,et al. Chondroitinase ABC Promotes Sprouting of Intact and Injured Spinal Systems after Spinal Cord Injury , 2006, The Journal of Neuroscience.
[2] A. Akaike,et al. Pregnenolone sulphate attenuates AMPA cytotoxicity on rat cortical neurons , 2005, The European journal of neuroscience.
[3] J. Cidlowski,et al. Mechanisms of glucocorticoid receptor signaling during inflammation , 2004, Mechanisms of Ageing and Development.
[4] Maiken Nedergaard,et al. New roles for astrocytes (stars at last) , 2003, Trends in Neurosciences.
[5] D. Snow,et al. Neurite elongation on chondroitin sulfate proteoglycans is characterized by axonal fasciculation , 2003, Experimental Neurology.
[6] M. Tuszynski,et al. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury , 2003, Experimental Neurology.
[7] Wutian Wu,et al. Axonal regeneration of Clarke’s neurons beyond the spinal cord injury scar after treatment with chondroitinase ABC , 2003, Experimental Neurology.
[8] O N Hausmann,et al. Post-traumatic inflammation following spinal cord injury , 2003, Spinal Cord.
[9] Robert Schweitzer,et al. Glucocorticoid receptor antagonism by cyproterone acetate and RU486. , 2003, Molecular pharmacology.
[10] Sylvan S Shank,et al. Glucocorticoids reduce responses to AMPA receptor activation and blockade in nucleus tractus solitarius. , 2003, American journal of physiology. Heart and circulatory physiology.
[11] C. Feuerstein,et al. Chondroitin and keratan sulfates have opposing effects on attachment and outgrowth of ventral mesencephalic explants in culture , 2002, Journal of neuroscience research.
[12] James W. Fawcett,et al. Chondroitinase ABC promotes functional recovery after spinal cord injury , 2002, Nature.
[13] J. Fawcett,et al. Chondroitin sulphate proteoglycans in the CNS injury response. , 2002, Progress in brain research.
[14] R. Gold,et al. Microglial Phagocytosis of Apoptotic Inflammatory T Cells Leads to Down-Regulation of Microglial Immune Activation1 , 2001, The Journal of Immunology.
[15] Gyeong-Moon Kim,et al. Glucocorticoid Receptor-Mediated Suppression of Activator Protein-1 Activation and Matrix Metalloproteinase Expression after Spinal Cord Injury , 2001, The Journal of Neuroscience.
[16] J. Fawcett,et al. Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes , 2000, The Journal of Neuroscience.
[17] M. Jurynec,et al. The Chondroitin Sulfate Proteoglycans Neurocan and Phosphacan Are Expressed by Reactive Astrocytes in the Chronic CNS Glial Scar , 1999, The Journal of Neuroscience.
[18] C. Haas,et al. Entorhinal Cortex Lesion in Adult Rats Induces the Expression of the Neuronal Chondroitin Sulfate Proteoglycan Neurocan in Reactive Astrocytes , 1999, The Journal of Neuroscience.
[19] Douglas K. Anderson,et al. Chondroitin Sulfate Proteoglycan Immunoreactivity Increases Following Spinal Cord Injury and Transplantation , 1999, Experimental Neurology.
[20] V. Perry,et al. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord , 1999, The European journal of neuroscience.
[21] V. Perry,et al. Cytokine-induced acute inflammation in the brain and spinal cord. , 1999, Journal of neuropathology and experimental neurology.
[22] E. Powell,et al. Dissection of astrocyte‐mediated cues in neuronal guidance and process extension , 1999, Glia.
[23] J. Xu,et al. Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats. , 1998, Brain research. Molecular brain research.
[24] Jerry Silver,et al. Activated Macrophages and the Blood–Brain Barrier: Inflammation after CNS Injury Leads to Increases in Putative Inhibitory Molecules , 1997, Experimental Neurology.
[25] J. Silver,et al. Glial cell extracellular matrix: boundaries for axon growth in development and regeneration , 1997, Cell and Tissue Research.
[26] A. Cato,et al. Molecular mechanisms of anti‐inflammatory action of glucocorticoids , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.
[27] Kahori Yamada,et al. AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[28] C. Finch,et al. Transcriptional regulation of glial fibrillary acidic protein by corticosterone in rat astrocytes in vitro is influenced by the duration of time in culture and by astrocyte-neuron interactions. , 1995, Endocrinology.
[29] M. Schwab,et al. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat , 1995, Brain Research.
[30] M. Norenberg,et al. Astrocyte Responses to CNS Injury , 1994, Journal of neuropathology and experimental neurology.
[31] V Balasingam,et al. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[32] W. Young,et al. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. , 1994, Journal of neurosurgery.
[33] J. Silver,et al. β-Amyloid of Alzheimer's Disease Induces Reactive Gliosis That Inhibits Axonal Outgrowth , 1993, Experimental Neurology.
[34] A. Caplan,et al. Structural domains in chondroitin sulfate identified by anti-chondroitin sulfate monoclonal antibodies. Immunosequencing of chondroitin sulfates. , 1993, Matrix.
[35] F. Besnard,et al. Analysis of a Segment of the Human Glial Fibrillary Acidic Protein Gene That Directs Astrocyte‐Specific Transcription , 1993, Journal of neurochemistry.
[36] M. Eddleston,et al. Molecular profile of reactive astrocytes—Implications for their role in neurologic disease , 1993, Neuroscience.
[37] L. Hösli,et al. Receptors for neurotransmitters on astrocytes in the mammalian central nervous system , 1993, Progress in Neurobiology.
[38] M. Sparkes. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data , 1992 .
[39] M. Bracken,et al. The Second National Acute Spinal Cord Injury Study. , 1990, Journal of neurotrauma.
[40] W. Collins,et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. , 1992, Journal of neurosurgery.
[41] J. Silver,et al. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[42] K. McCarthy,et al. Astroglia in culture , 1991 .
[43] M. Bracken,et al. Treatment of acute spinal cord injury with methylprednisolone: results of a multicenter, randomized clinical trial. , 1991, Journal of neurotrauma.
[44] J. Sarid. Identification of a cis‐acting positive regulatory element of glial fibrillary acidic protein gene , 1991, Journal of neuroscience research.
[45] M. Karin,et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction , 1990, Cell.
[46] Stephan Gebel,et al. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone , 1990, Cell.
[47] M. Bracken. Methylprednisolone in the management of acute spinal cord injuries , 1990, The Medical journal of Australia.
[48] J. Silver,et al. Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro , 1990, Experimental Neurology.
[49] C. Hsu,et al. Methylprednisolone in spinal cord injury: the possible mechanism of action. , 1990, Journal of neurotrauma.
[50] D. Choi,et al. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay , 1987, Journal of Neuroscience Methods.
[51] E. Hall,et al. Lipid hydrolysis and peroxidation in injured spinal cord: partial protection with methylprednisolone or vitamin E and selenium. , 1985, Central nervous system trauma : journal of the American Paralysis Association.
[52] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[53] E. Hall,et al. Acute effects of intravenous glucocorticoid pretreatment on the in vitro peroxidation of cat spinal cord tissue , 1981, Experimental Neurology.
[54] A. Bignami,et al. Immunogenic properties of the glial fibrillary acidic protein , 1976, Brain Research.
[55] A. Bignami,et al. Heterogeneity of the glial fibrillary acidic protein in gliosed human brains. , 1974, Journal of the neurological sciences.
[56] A. Bignami,et al. Astrocyte‐specific protein and neuroglial differentiation. An immunofluorescence study with antibodies to the glial fibrillary acidic protein , 1974, The Journal of comparative neurology.
[57] L. Eng,et al. Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. , 1972, Brain research.